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Abstract_______________________________________________________________________________________
Given the limited regenerative capacity of the mammalian retina, cell-replacement strategies are necessary. To
replace photoreceptors lost to disease or trauma and restore visual function, laboratories throughout the world are
researching photoreceptors replacement strategies using subretinal transplantation of retinal progenitor cells
(RPCs). A major obstacle to the advancement of photoreceptor cell-replacement strategies includes low rates of
invasion and integration of transplanted cells into the host retina. Currently, there is a limited understanding of how
RPC glycolysis may facilitate invasion. To further understand RPC glycolysis-driven invasion, the current investigation
involved the bioenergetic modulation RPCs for glycolysis analysis and invasion modeling. The glycolysis analysis
detected the concentration of glycolytic-lactate secreted by the cells, while the invasion modeling captured the
number of invasive cells. We report here that RPCs treated with glucose, secreted increased glycolytic-lactate and
exhibited increased invasion in a concentration-dependent manner. Our results demonstrate that the invasion of
RPCs is energetically influenced by glycolysis. Thus, imparting glycolysis as a key component in the invasion of RPCs.
This work extends our understanding of the bioenergetic needs of RPC invasion.
1. Introduction_________________________________________________________________________________
Rod and cone photoreceptors are light-detecting neurons, and their loss is a major characteristic of disease-induced
photoreceptor degeneration that leads to blindness (1-4). Growing populations are at risk of photoreceptor
degeneration due to eye diseases (e.g., age-related macular degeneration, retinitis pigmentosa) (3-5). The human
eye does not replace lost or damaged photoreceptors due to ineffective regeneration of the central nervous system
(CNS) (6). The regenerative ability of the adult mammalian CNS is limited, both in the generation of new neurons
and in the restoration of synaptic pathways (6).
Cell-replacement is a promising strategy as it is feasible and uses transplantable cells such as retinal
progenitor cells (RPCs) that can differentiate into new photoreceptors, replacing lost photoreceptors (3,6). Low
rates of invasion of transplanted cells into the host retina remains a significant obstacle (3). Cell invasion is described
as the migration of cells within and across tissue layers (7). Following transplantation into the subretinal space, the
path of invasion into the retina requires RPCs to cross the interphotoreceptor matrix (IMP) and migrate into the
retinal outer nuclear layer where photoreceptors are localized. Little is known about the energetics and invasive
machinery used by RPCs that successfully invade retinal tissue. Interestingly, detachment from the primary site and
migration to distant sites is a salient trait of proliferating invasive cancer cells (8). Although the mechanism by which
cancer cells may gain an invasive phenotype remains poorly understood, their survival and motility are energetically
dependent on glycolysis (8, 9). The bioenergetic pathway, glycolysis, can be a critical component of the invasion of
RPCs.
1.1. The Bioenergetics of Photoreceptors
Human photoreceptors have a unique bioenergetic pathway that is not fully understood (10). In the retina, oxidative
phosphorylation (OXPHOS) is a significant source of ATP, and the most oxygen-consuming region is the
mitochondrially-rich inner segments of the photoreceptors (10). However, mammalian photoreceptors exhibit
increased glycolysis, competing for glucose and producing substantial quantities of lactate despite the abundance of
oxygen (1,8,10-13). Glycolysis facilitates the conversion of one glucose molecule into two pyruvate molecules,
followed by the production of lactate, NAD+, and ATP (14). The use of glycolysis is a less efficient form of energy
production (14). A cell can produce 38 ATP molecules during OXPHOS; however, only 2 ATP molecules are generated
during glycolysis (14). The 19-fold rise in ATP via OXPHOS appears to be more advantageous to the cell, mainly as
glucose can be used as the starting material in both pathways (14). Glycolysis, however, is essential during hypoxia
(anaerobic) periods and occurs even when oxygen (aerobic) is present (5,14). The explanation behind this peculiar
bioenergetic pathway, which is indicative of invasive cancer cells, remains unclear, but what is clear is that
photoreceptors are energy-intensive.
Glycolysis contributes 80 to 90 percent of the glucose used by photoreceptors (1,15). In the retina, via
glycolysis, 80 to 96 percent of glucose is turned into lactate (2,13,16). Photoreceptors not only use lactate as fuel
(17) but also secrete it into the IPM (1,11-13,14). The transport of glucose to the outer retina, including the
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photoreceptor layer, via glucose transporters (GLUTs), and the transport of lactate out of the retina via
monocarboxylate transporters (MCTs) is facilitated by the retinal pigment epithelium (RPE) (13). In the case of RPE
cells, their glucose use is low, and the photoreceptor-produced lactate fuels their bioenergetic needs and increases
the transport of glucose across the outer blood-barrier (13). Lactate also drives glycolytic activity in Müller cells,
which work to preserve retinal integrity and homeostasis (16). The interdependence of glucose uptake, glycolysis,
and lactate synthesis as a "bioenergetic ecosystem" is vital, not only for photoreceptors but also for invasive cancers,
which upregulate glycolysis and ATP production to migrate and invade the adult retina and CNS (13,18).
1.2. The Bioenergetics of Photoreceptors Resembles that of Invasive Cancer
Invasive cancer cells, similar to photoreceptors, use glucose at a high level and convert it to lactate instead of relying
on OXPHOS to generate energy (1,8,10-13). This occurs while metastatic cells detach from the primary tumors and
invade distant tissues, even if sufficient oxygen is present (8, 19, 20). Cancer cells preferring to upregulate glucose
consumption and lactate production under oxygenated conditions is termed the Warburg effect or aerobic glycolysis
(8,19- 22). The term aerobic glycolysis was developed by Otto Warburg in the early 19 th century to describe the
distinctive bioenergetics of tumor cells (20-23). The conversion of glucose into lactate under anaerobic conditions
(limited oxygen) was already described by Warburg as anaerobic glycolysis; he then described the bioenergetic
pathway of cancer cells as aerobic glycolysis to point out that the lack of oxygen does not control the fate of glucose
and lactate production. (20,21,23). Nevertheless, following Warburg's findings, lactate was still regarded as a deadend waste product in times of insufficient oxygen (20,24). The end-product of glycolysis was consistently interpreted
dichotomously: as pyruvate in the presence of oxygenation and as lactate in the absence of oxygenation (24).
However, our understanding of lactate formation has changed much since then. At the end of the late 20th and
early 21st centuries, it was learned that oxygen is not limited to OXPHOS in most cellular conditions and that lactate
is produced even when the rate of oxygen delivery to mitochondria is not restricted (24). Furthermore, given that
(a) the reaction of lactate dehydrogenase (LDH), which catalyzes the conversion of pyruvate to Lactate, is of a nearequilibrium reaction, for the equilibrium constant favors lactate; (b) LDH has more significant activity than other
proposed glycolytic enzymes and oxidative pathways; (c) even in the absence of lactate accumulation; and (f) in the
presence of adequate oxygen, glycolysis always produces lactate as an end-product (24).
Glycolysis can be used as a cell viability indicator as it contributes to cell proliferation by providing better
protein/nucleotide synthesis than OXPHOS (14,25). Amassing evidence shows that high tumor glycolysis supports
not only the growing need for ATP, but also cell proliferation and survival by influencing signaling pathways and
raising the production of proteins, nucleic acids, and lipids (8). Increased glucose uptake and lactate accumulation
help tumor cells fulfill these proliferative requirements, which may be why glycolysis is a prominent characteristic of
many proliferating cells (25).
The functional significance of the glycolytic switch in invasive cancer cells has been attributed to
mitochondrial dysfunction, hypoxic adaptation, oncogenic signals, modified metabolic enzymes, and increased
bioenergetic demands to support membrane transporter activity needed for cell division, growth, and invasion (8).
The glycolysis switch leads to the increase of glucose uptake through increased expression of glucose transporter
(GLUT1 and GLUT3) proteins in invasive cancers, which then increases the expression of LDH (26,27). LDH increases
lactate production and accumulation and, in turn, upregulates the lactate transporter monocarboxylate transporter
(MCT4) and its stabilizer, CD147, for lactate export (18,26-28). CD147 is an extracellular matrix metalloproteinase
(MMP) cell surface glycoprotein that enhances the ability of tumor cells to invade the extracellular matrix (ECM).
The MCT4/CD147 complex transports newly formed lactate out of the cell. At the same time, lactate is taken from
the bloodstream and turned back to pyruvate inside the cancer cell for the use in the citric acid cycle, supporting the
continuous conversion of pyruvate into lactate and lactate into pyruvate; therefore, cancer cells both release and
capture lactate and, maintain continuous glycolysis (26,27).
MCT4/CD147 preferentially interacts with cell surface molecule B1-integrins (29,30). B1-integrins, once
activated, mediate the attachment of the cytoskeleton to the ECM (29,31). B1-integrin mediates the formation of
force-generating adhesions to the ECM and assembly of the actin cytoskeleton during cell migration, establishing a
bridge from the actin cytoskeleton to the ECM (29,31). Increases in cytoskeleton remodeling, chemotaxis, and
invasion are linked to the upregulation of glycolysis in invasive cancers (8).
6|P a g e

Furthermore, previous studies have demonstrated the impact and importance of the knockdown of glucose
transporters, pyruvate, lactate, lactate transporters, CD147, and B1-integrins on migration and invasion. In
summary, the knockdown resulted in a decrease in (migration, invasion, glucose uptake, lactate production, Ncadherin, filopodia, gap-junction proteins, migration, and invasion) and an increase in E-cadherin (Table 1).
Table 1: Knockdown of genes driving migration and invasion from glycolysis
Gene

Knockdown Effect

Glucose Transporter
(GLUT1)

Decreases cell proliferation, glucose uptake, lactate production, migration, invasion, and
expression of B1-integrin (32).

Glucose Transporter 3
(GLUT3)

Decreases (glucose uptake, lactate production, migration, invasion, and N-cadherin (cell
mobility marker)) and increase E-cadherin (cell-cell adhesive marker) (33).

Pyruvate Kinase (Pyruvate)

Decreases migration and invasion (34).

LDH (Lactate)

Decreases (glucose uptake, lactate production, migration, and invasion), and increase Ecadherin (35,36).

MCT4

Decreases (lactate release, migration, invasion, and MMP activity), and increase focal
adhesion size (rapidly moving cells have small focal adhesion size) (18,29,30,37-39).

CD147

Decreases (filopodia, migration, and invasion), increased (expression of cell-cell adhesion and
gap junction proteins), and Induced expression of E-cadherin (18,30).

B1-Integrin

Decreases cell adhesion to ECM, increases migration and invasion (30,31,40).

1.3. Transplantable RPCs
A promising experimental approach, the replacement of photoreceptors by subretinal transplantation of donor cells,
is under investigation (3). Recent cell replacement studies have shown that the use of transplantable cultureexpanded RPCs is feasible and that RPCs can develop and mature into efficient photoreceptor neurons in their new
surroundings, forming new synaptic connections replacing dying photoreceptors (3,41). However, the low rate of
transplanted RPC invasion into the retina is a major obstacle (3). RPCs must first invade through the IPM, which
occupies the subretinal space between the photoreceptor neurons and the RPE (42, 43). Next, RPCs must invade
the outer nuclear layer containing host photoreceptor cell bodies.
1.4. RPC Transplantation and Glycolysis
During transplantation, RPCs are injected into the subretinal space, where the inner segments of photoreceptors are
localized, and where oxygen levels range from 40 to 50 mmHg (44). Normal arterial oxygen ranges from 75 to 100
mmHg, and values below 60 mmHg typically indicate the need for oxygen supplementation (45). The oxygen
concentration that RPCs must survive is between 40 to 50 mmHg (44); in this hypoxic environment, glycolysis is
essential (5,14). The examination across the IPM of both bovine and rabbit retinas showed that the distribution of
glucose and lactate changes from the IPM to the photoreceptors (PR) and from the IPM to the retinal pigment
epithelium (RPE), there remained low glucose and high lactate concentrations in each area studied (Table 2) (42).
Additionally, in the bovine model, glucose levels were lower, and lactate levels were higher across the IPM compared
to blood glucose and blood lactate (Table 2) (42). Furthermore, another study found 4 mM glucose and 18 mM
lactate in the rabbit retina, and 22-33 mM lactate in both cat and rat retinas (42).
The degree of visual function restored rests on the number of RPCs that can invade, migrating from within
the subretinal space through the IPM to join the remaining photoreceptors (1-4). In the present study, we set out
to investigate the bioenergetic modulation of RPC glycolysis and its influence on invasion. Firstly, we looked at the
role of glucose supplementation in RPC lactate production. Next, we analyzed the effect of glucose supplementation
and lactate production on the invasion of RPCs in an in vitro invasion assay. In summary, the interaction of glycolysis
with the invasive potential of RPCs was analyzed. The data provides a window into the complex process of RPC
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invasion for photoreceptor replacement. This work may help explain the currently undefined bioenergetics of RPCs
transplanted into the subretinal space and provide glycolytic targets that may be upregulated to increase invasion,
thereby increasing transplantation outcomes.
Table 2: Glucose and lactate concentration in the Bovine and Rabbit IMP structural units IPM-PR and IPM-RPE (42).
Bovine Compartment (2 to 5 hours post-mortem)
Glucose mM
Lactate mM
IPM-PR

0.01

13

IPM-RPE

0.9

3.8

Blood

4.4

0.8

Rabbit Compartment (immediately after death to minimized post-mortem
glycolysis)
IPM-PR

0.0

1.6

IPM-RPE

1.6

5

2. Materials and Methods________________________________________________________________________
2.1. Cell Culture
Neurons and neural stem cells survive in a neural basal glucose-free medium for up to 24 hours (46). Mouse retinal
progenitor cells (mRPCs), a gift from Dr. Young from Harvard University, were cultured in Glucose-free Neural Basal
medium supplemented with N2, B27, Nystatin, mEGF, Pen/Strep, and L-Glutamine. The cells were maintained in a
5% CO2 atmosphere at 37℃.
2.2. RPC Glucose Concentration Culture
RPCs (5x106) were cultured in increasing concentrations of glucose from 0-60 mM (n=4, independent
samples/concentration) for 24 hours at 37℃. Following RPC glucose treatment, lactate concentration in culture
medium was measured. Glucose pre-treatment was also performed for 24 hours prior to RPCs being transferred to
transwells for invasion analysis.
2.3. Glycolysis Lactate Assay
The EnzyChrom glycolysis assay kit was used to determine the lactate production of RPCs (BioAssay Systems,
Hayward, CA, USA) according to the manufacturer's instructions. This allows glycolysis to be assessed using the
medium lactate level, which is directly proportional to the glycolytic rate of the cells. The concentration of L-Lactate
in a culture medium at 24 hours from the above-described conditions was measured using 5 μL of conditioned
medium mixed with EnzyChrom reagents and detected by spectrophotometry at 565 nm. The results were
compared with a standard curve generated by known lactate concentrations.
2.4. RPC Invasion Assay
A transwell invasion assay was used to assess RPC invasion, using an 8 μm pore-sized membrane. The upper surfaces
were coated with Matrigel, and the lower chambers were coated with Poly-L-Lysine (PPL) meant to mimic the typical
matrices that cells encounter during the invasion process in vivo. To coat the transwells, 100 μL of Matrigel was
added to the upper chambers, and 750 μL of PPL was added to the lower chambers and incubated at 37°C for 1 hour.
Then, the coated transwells were washed twice with sterile water for 5 minutes each time and afterward stored at
4 °C overnight. Prior to the experiment, the coated transwells were placed in the tissue-cultured hood at room
temperature for 2 hours. After 24 hours of glucose treatment, cells were harvested from 24-well plates and pipetted
into the upper chambers of the transwells. 750 μL of glucose-free NB medium was added to the lower chambers.
The invasion assay lasted for 24 hours at 37°C. Non-invasive cells were scraped from the upper membrane surface,
then 750 μL of 4% paraformaldehyde (PFA) was added to the bottom chamber for 20 minutes to fix invading cells.
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After cell fixation, the transwells were rinsed twice with 750 μL of PBS. Finally, Coomassie Brilliant Blue R250 was
used for staining. Invading cells were imaged using Floid Cell Imaging Station at 20X and counted using 40 to 60
camera fields per membrane.
2.5. Statistical Analyses
Data were analyzed using Graphpad Prism Software (GraphPad Software Inc., La Jolla, CA, USA,
www.graphpad.com). Data were presented as mean∓standard deviation. Differences between groups were
measured using a Student's t-test. P<0.05 was considered to indicate a statistically significant difference.
3. Results_____________________________________________________________________________________

Optical Density at 565 nm

3.1. Glucose Concentration-Responses
Eighty to ninety percent of glucose that photoreceptors consume is contributed from glycolysis, and eighty to ninetysix percent of the consumed glucose is converted to lactate (1,2,13,15,16), which is known to fuel photoreceptors
(17). We hypothesize that exposure of mRPCs to increased glucose concentrations will activate glycolysis and lactate
production. It has been shown that high glucose concentrations in the range of 5 to 40 mM and high lactate
concentrations from 10 mM to 20 mM do not reduce the viability of neurons or neural stem cells in normoxic or
anoxic conditions (46). In this work, mRPCs were treated in glucose-free neurobasal medium (control) or with
glucose concentrations from 0 mM, 7.5 mM, 15 mM, 30 mM, and 60 mM. Lactate levels were detected using the
EnzyChrom glycolysis assay kit and sampling 5ul of conditioned culture medium in each condition following 24 hours
of incubation. Next, a standard curve using standard lactate concentration was established using the Glycolysis Kit
(Figure 1). The standard curve was used to assess the glycolytic-lactate secreted by glucose-free and glucose-treated
mRPCs after 24 hours of incubation (Figure 2). The results showed that lactate levels increased with increased
glucose concentrations (Figure 2). Results indicate that RPCs respond to increasing glucose concentrations by
synthesizing more Lactate.
2
1.5
1
0.5
0
0

2

4

6

8

10

12

[L-Lactate] mM Standards
Figure 1. Standard Curve to Measure Activation of Glycolytic-Lactate Production.
Four lactate standard concentrations of 0 mM, 3 mM, 6 mM and 10 mM produced values of 0.1663, 0.4653, 0.884, and
1.596 and a slope of 0.1483, respectively. This slope, with the formula [L-Lactate] (mM) = (OD Sample – OD Blank)/Slope
(mM-1), was used to determine the L-lactate concentration of mRPCs in (Figure 2). The standards were measured using
the EnzyChrom (Bioassay systems) glycolysis assay kit and Gen 5 plate reader at an optical density of 565 nm.
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Figure 2. 24 hours mRPCs Glucose Incubation to Measure Glycolytic-Lactate Production.
Mouse retinal progenitor cells (mRPCs) were incubated at 37℃, in increasing concentrations of glucose (0 mM, 7.5 mM,
15 mM, 30 mM and 60 mM) for 24 hours. mRPCs (5.0 x106 /well, n=4 each) produced 0 mM, 0.0112 mM, 0.1349 mM,
2.7242 mM, and 3.0231 mM, respectively. Lactate production was measured using the EnzyChrom (Bioassay systems)
glycolysis assay kit and Gen 5 plate reader at an optical density of 565nm.

3.2. Glycolytic Rate and Invasion
Given that photoreceptors, similar to many invasive cancer cells, exhibit increased glucose consumption and lactate
production via glycolysis, we hypothesized that glycolysis stimulation in mRPCs would increase invasion in an in vitro
invasion assay. Previous studies used glucose concentrations of 5 mM, 25 mM, and 30 mM to drive invasion in
cancer cells (47-51). We decided to use 30 mM, given it was the concentration shown to drive the highest amount
of invasion. mRPCs were treated in glucose-free medium or in a glucose concentration of 30 mM.

Optical Density at 565 nm

To detect the glycolytic rate of mRPCs, we first established a standard curve with the known lactate
concentrations using the Glycolysis Kit (Figure 3). The standard curve was used to assess the glycolytic-lactate
synthesized by glucose-free and glucose-treated mRPCs after 24 hours of incubation (Figure 4). The glycolytic rate
of mRPCs under 0 mM and 30 mM glucose was compared. The data showed that lactate levels increased with
increased glucose levels (Figure 4). In addition, the lactate yield of mRPCs exposed to 30 mM glucose was
significantly higher relative to mRPCs not exposed to glucose and glycolytic-lactate (Figure 4).
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12

L-Lactate mM Standards
Figure 3. Standard Curve to Measure Activation of Glycolytic Lactate Production.
Four Lactate standards with 0 mM, 3 mM, 6 mM, and 10 mM at 37℃, produced observance values of 0.058, 0.391, 0.806,
and 1.1183 and a slope of 0.1084, respectively. This slope, with the formula, [L-Lactate] (mM) = (OD Sample – OD
Blank)/Slope (mM-1), was used to determine the L-lactate concentration of mRPCs in (figure 4). The standards were
measured using the EnzyChrom (Bioassay systems) glycolysis assay kit and Gen 5 plate reader at an optical density of
565nm.
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Figure 4. Glycolysis Analysis of Glucose-Free and Glucose-Treated mRPCs.
mRPCs were incubated in glucose concentration (0 mM and 30 mM) at 37℃ for 24 hours to measure glycolytic Lactate
production. Lactate production was measured using the EnzyChrom (Bioassay systems) glycolysis assay kit and Gen 5 plate
reader at an optical density of 565nm. Cell suspension of (5.0x104 ) mRPCs produced 0.0278 mM and 1.7808 mM of Lactate
concentration resulting in a P-value of 0.0280; this difference is considered to be statistically significant.

We next examined the invasive ability of mRPCs pre-treated with 0 mM or 30 mM of glucose for 24 hours.
We used Matrigel coated-transwells to measure the effect of glycolysis modulation on RPC invasion. Cells were
seeded on transwells insert as described previously. RPCs that invaded the Matrigel and passed through the
membrane after 24 hours of incubation (Figure 5). We found that mRPCs exposed to 30 mM glucose resulted in
significantly higher invasion compared to mRPCs not exposed to glucose and glycolytic-lactate (Figure 6). These
findings show that when glucose and lactate were present, the number of invasive cells was significantly higher. In
contrast, glucose-free RPCs had a minimal number of invasive cells (Figure 6). Taken together, these results indicate
that glucose-treated mRPCs have significantly higher glycolysis and invasive activity relative to glucose-free mRPCs.

Figure 5. The Visual Analysis of the Morphology and Distribution of mRPCs on Coated-Transwells.
Cells were seeded at a density of 2.5 x 10 4. After 24 hours of incubation at 37C° and 20X, (A) glucose-free mRPCs, and (B)
glucose-treated mRPCs. The white arrows point to invasive mRPCs, while the yellow triangles point to the transwell
membrane pores. The samples were viewed under the Floid Cell Imaging Station and stained with Coomassie Brilliant Blue
R250.
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Average Number of Cells

The morphology of invading RPCs appeared similar between conditions. RPCs visualized on the underside
of the transwell membranes exhibit elongated soma with extended processes (Figure 5). Both glucose-free and
glucose-treated RPCs invaded either individually or adhering to each other. This may suggest that they were able to
sense the transwell membrane and, in turn, apply the necessary forces to invade without experiencing impairment
to their de-adhesive and adhesive capacity, which are crucial to cancer cell invasion (52,53). As a result, since
significantly fewer glucose-free RPCs were able to invade, the lack of glycolysis stimulation may have impaired their
de-adhesive and adhesive ability considerably. Therefore, glycolysis stimulation may have facilitated the deadhesion and adhesion process of invasion in glucose-treated RPCs.

500

*

400
300
200
100
0
0

30
[D-Glucose] mM

Figure 6. 24 hours Transwell Invasion Analysis of Glucose-Free and Glucose-Treated mRPCs.
Cell suspension of (2.5x104 ) of mRPCs per transwell were incubated in 0 mM and 30 mM Glucose concentrations for 24
hours to measure invasive activity. On average, 38 Glucose-free mRPCs in comparison to 333 Glucose-treated mRPCs
invaded the coated permeable membrane of the transwells resulting in a P-value of 0.0066; this difference is considered
to be statistically significant.

In summary, the data provides new evidence supporting that higher glucose consumption in mRPCs is
associated with greater lactate production, higher glycolysis, and invasion. RPC motility may, therefore, be
energetically dependent on glycolysis during the invasion, and modulation of this pathway may improve invasion of
photoreceptor replacement outcomes.
4. Conclusion_________________________________________________________________________________
Photoreceptors consume glucose faster than any other healthy tissue and produce high levels of lactate at the end
of the glycolysis pathway (42). High dependence on glycolysis is widely accepted as one of the most salient
bioenergetic characteristics of both photoreceptors and invasive cancer cells. Glycolysis dependent pathways also
drive the remodeling of cytoskeletons and attachment to the ECM (8), which are crucial for the invasion of RPCs and
cancer cells, given that they need to detach when they migrate from the primary site to reattach to the secondary
site while invading microenvironments. Also, the application of exogenous lactate has been shown to result in
increased motility (30). Extracellular Lactate has been shown to upregulate the ECM proteins, hyaluronan, and type
I collagen, which improves migration (30), and the increase in lactate increases B1-integrins, which increases invasion
(29,30). We suggest that the pathway for lactate acidosis increase in photoreceptors is similar to the increase in
invasive cancer cells. In this work, we sought to understand the role of bioenergetic modulation of glycolysis on
mRPCs during their invasion. We found that glycolytic stimulation considerably influences the invasion of mRPCs.
Glucose-treated mRPCs exhibit high glycolysis and invasive capacity over glucose-free mRPCs. Accumulation of
glycolytic-lactate with increased glucose concentrations observed in invasive mRPCs cultured in glucose-free
medium in this investigation suggests that providing the bioenergetic source via glycolysis for cell invasion is
favorable, and that lactate may serve as a motility mediator during their invasion process. In general, our glucosetreated cells show significantly high levels of glycolysis and invasion in vitro.
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